Nothing seems to bother Qualigen Therapeutics (NASDAQ:QLGN)

Earnings results for Qualigen Therapeutics (NASDAQ:QLGN)

Qualigen Therapeutics, Inc. is estimated to report earnings on 08/13/2021. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. The reported EPS for the same quarter last year was $-0.27.

Qualigen Therapeutics last issued its quarterly earnings results on May 14th, 2021. The reported ($0.21) earnings per share (EPS) for the quarter. The company earned $1.90 million during the quarter, compared to analyst estimates of $1.30 million. Qualigen Therapeutics has generated $0.00 earnings per share over the last year. Qualigen Therapeutics has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Friday, August 13th, 2021 based off prior year’s report dates.

Analyst Opinion on Qualigen Therapeutics (NASDAQ:QLGN)

1 Wall Street analysts have issued ratings and price targets for Qualigen Therapeutics in the last 12 months. There are currently 1 buy rating for the stock, resulting in a consensus rating of “Buy.”

There is not enough analysis data for Qualigen Therapeutics.

Dividend Strength: Qualigen Therapeutics (NASDAQ:QLGN)

Qualigen Therapeutics does not currently pay a dividend. Qualigen Therapeutics does not have a long track record of dividend growth.

Insiders buying/selling: Qualigen Therapeutics (NASDAQ:QLGN)

In the past three months, Qualigen Therapeutics insiders have not sold or bought any company stock. Only 4.70% of the stock of Qualigen Therapeutics is held by insiders. Only 6.52% of the stock of Qualigen Therapeutics is held by institutions.

Earnings and Valuation of Qualigen Therapeutics (NASDAQ:QLGN

More latest stories: here